Short answer
Apogee Therapeutics, Inc. (APGE) filed an 8-K current report with the SEC on June 12, 2026 reporting Item 5.07 (Submission of Matters to a Vote of Security Holders). Shareholders elected all three Class III nominees to serve until the 2029 annual meeting.
Apogee Therapeutics, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.07 · Submission of Matters to a Vote of Security Holders
- Shareholders elected all three Class III nominees to serve until the 2029 annual meeting
- William (BJ) Jones Jr. received 10,240,447 withheld votes, indicating comparatively weaker shareholder support
- Ernst & Young’s appointment for fiscal 2026 ratified with 56,960,778 votes for and 1,361 against
- Executive compensation approved on a non-binding advisory basis with 54,324,725 votes for
- 61,853,254 voting shares outstanding as of the April 15, 2026 record date
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Apogee Therapeutics, Inc. 8-K filings
Get the next APGE 8-K as it lands
Follow APGE for push alerts, or ask the research agent what this filing means.